Search PubMed⌕ Search

PubMed · 7648828

An optical practice based diabetic eye screening programme.

Abstract

In many cases, blindness due to diabetic retinopathy can be prevented provided treatment with laser photocoagulation is used at the correct time. A screening programme is required to identify cases of sight threatening retinopathy. An optical practice based diabetic eye screening programme has been established in Dorset. The optometrist undertaking the examination is paid a fee. The findings are recorded on a coded form and sent to the hospital diabetologist who recalls positive cases. Seventy-six optical practices have joined the scheme and 3224 patients have been screened in the first 6 months (Dorset population 655,000). In the Poole area (population 230,000), 1922 patients were screened and 129 (6.7%) were recalled in 6 months. Outcome of 3 months screening, identified 59 recalls. Referral to the opthalmologist was made in 15 cases for potentially sight threatening retinopathy, 14 cases were followed in the diabetic clinic for significant background retinopathy, and 24 cases were returned to the annual screening in the optical practices. Six cases where the patients either failed or were unable to attend were reviewed by the GP. An optical practice based diabetic eye screening programme has been successful in screening a large number of patients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W Gatling, A J Howie, R D Hill. 1995. An optical practice based diabetic eye screening programme.. https://doi.org/10.1111/j.1464-5491.1995.tb00536.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The Hermann-Hering grid illusion demonstrates disruption of lateral inhibition processing in diabetes mellitus.

BACKGROUND/AIM: The Hermann-Hering grid illusion consists of dark illusory spots perceived at the intersections of horizontal and vertical white bars viewed against a dark background. The dark spots originate from lateral inhibition processing. This illusion was used to investigate the hypothesis that lateral inhibition may be disrupted in diabetes mellitus. METHOD: A computer monitor based psychophysical test was developed to measure the threshold of perception of the illusion for different bar widths. The contrast threshold for illusion perception at seven bar widths (range 0.09 degrees to 0.60 degrees) was measured using a randomly interleaved double staircase. Convolution of Hermann-Hering grids with difference of Gaussian receptive fields was used to generate model sensitivity functions. The method of least squares was used to fit these to the experimental data. 14 diabetic patients and 12 control subjects of similar ages performed the test. RESULTS: The sensitivity to the illusion was significantly reduced in the diabetic group for bar widths 0.22 degrees, 0.28 degrees, and 0.35 degrees (p = 0.01). The mean centre:surround ratio for the controls was 1:9.1 (SD 1.6) with a mean correlation coefficient of R(2) = 0.80 (SD 0.16). In the diabetic group, two subjects were unable to perceive the illusion. The mean centre:surround ratio for the 12 remaining diabetic patients was 1:8.6 (SD 2.1). However, the correlation coefficients were poor with a mean of R(2) = 0.54 (SD 0.27), p = 0.04 in comparison with the control group. CONCLUSIONS: A difference of Gaussian receptive field model fits the experimental data well for the controls but does not fit the data obtained for the diabetics. This indicates dysfunction of the lateral inhibition processes in the post-receptoral pathway.

Diabetic Retinopathy↗

[Screening for diabetic maculopathy].

Diabetic maculopathy (DMP) is an important but curable of eyesight losses in diabetic with type 1 and 2 diabetic mellitus (DM). In the submitted work the author investigates the pathogenesis of diabetic macular oedema (DME). Classification, diagnosis and standard of treatment of DMP, incl. the different therapeutic procedure used in concurrent DMP and proliferative diabetic retinopathy in DM type 1 and 2.

Diabetic Retinopathy↗